Fast disintegrating tablets: Opportunity in drug delivery system

Journal of Advanced Pharmaceutical Technology and Research

Volumn 2, Issue 4, 2011, Pages 223-235

  Parkash, Ved ^a   Maan, Saurabh ^a   Deepika, ^a   Yadav, Shiv ^a   Hemlata, H ^a   Jogpal, Vikas ^b  

^a B S Anangpuria Institute of Pharmacy   (India)

^b Department of Pharmacology   (India)

Author keywords

Fast dissolving tablets; freeze drying; spray drying; taste masking

Indexed keywords

CETIRIZINE; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN; DOLIB MD; DOLOROFF; DOMPERIDONE; DOMRAY MD; FAMOTIDINE; FENTANYL CITRATE; FLAVORING AGENT; FROSTA; GLIBENCLAMIDE; GRISEOFULVIN; HYDROCHLOROTHIAZIDE; IBUPROFEN; INDOMETACIN; INSURE MD; MANZA RDT; MONTELUKAST; MOSAPRIDE; MOSID MT; NENCY MD; NEXUS MD; NIMESULIDE; NIMEX MD; NIMEZ MD; NIMULID MD; OLANEX INSTAB; OLANZAPINE; OLNIM MD; ONDANSETRON; ORTHOREF MD; OXYBUTYNIN; PARACETAMOL; PARALYOC; PHARMABURST; PREDNISOLONE; PREDNISONE; PROMETHAZINE; PSEUDOEPHEDRINE; RBCOX 25 MD; ROFADAY MT; ROFECOXIB; ROFFEC MD; ROFTAB MD; SULBID MD; SWEETENING AGENT; TIZANIDINE; TOPMIDE; TORROX MT; TRIAMINIC; TRIAMINIC SOFTCHEW; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALDECOXIB; VELRID MD; VOMIDON MD; ZIFLAM; ZOFEX 25 MD; ZOLMITRIPTAN; ZOTACET MD;

BITTER TASTE; COMPRESSIVE STRENGTH; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG GRANULATION; DRUG RESEARCH; DRUG SOLUBILITY; FREEZE DRYING; HEAT TREATMENT; HUMAN; MASKING; MICROENCAPSULATION; MOISTURE; PH MEASUREMENT; PRIORITY JOURNAL; REVIEW; SPRAY DRYING; TABLET COMPRESSION; TABLET DISINTEGRATION TIME; TABLET FORMULATION; TABLET FRIABILITY; TABLET POROSITY; TASTE ACUITY; TREND STUDY;

EID: 84855243569     PISSN: 22314040     EISSN: 09762094     Source Type: Journal    
DOI: 10.4103/2231-4040.90877     Document Type: Review

References (104)

1. Zade PS, Kawtikwar PS, Sakarkar DM. Formulation, evaluation and optimization of fast dissolving tablet containing tizanidine hydrochloride. Inter J Pharm Tech Res 2009;1:34-42.
2. Ishikawa T, Watanabe Y, Utoquchi N, Matsumoto M. Preparation and evaluation of tablets rapidly disintegrating in saliva containing bitter-taste-masked granules by the compression method. Chem Pharm Bull 1999;47:1451-4. (Pubitemid 29510317)
3. Omaima SA, Mohammed HA, Nagia MA, Ahmed SZ. Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion. AAPS Pharm Sci Tech 2006;7: E1-9.
4. Simone S, Peter CS. Fast dispersible ibuprofen tablets. Eur J Pharm Sci 2002;15:295-305.
5. European Pharmacopoeia 5.0, Vol. 1.0, 5th ed, Strasbourg, France: 2005. p. 628.
6. Habib W, Khankari R, Hontz J. Fast-dissolve drug delivery systems. Crit Rev Ther Drug Carrier Syst 2000;17:61-72. (Pubitemid 30174149)
7. Li Q, Wei WX, Xiaofeng C, Tao H. Evaluation of disintegrating time of rapidly disintegrating tablets by a paddle method. Pharm Dev Tech 2006;11:295-305.
8. Vikas A, Bhavesh HK, Derek VM, Rajendra KK. Drug delivery: Fast dissolve systems. Encycl Phar Tech 2007;1:1104-14.
9. Sohi H, Sultana Y, Khar RK. Taste masking technologies in oral pharmaceuticals: Recent developments and approaches. Drug Dev Ind Pharm 2004;30:429-48. (Pubitemid 38821855)
10. Pondell, R. Taste masking with coatings, Coating technology, 1996.
11. Zelalem A, Vibha P, Lokesh K, Arvind KB. Trends in pharmaceutical taste masking technologies: A patent review. Recent Pat Drug Deliv Formul 2009;3:26-39.
12. Freudenberg K, Cramer F, Plieninger H. Inclusion compounds of physiologically active organic compounds. Ger Pat 1953;895769
13. Szejtli J, Szente L. Elimination of bitter, disgusting tastes of drugs and foods by cyclodextrins. Eur J Pharm Biopharm 2005;61:115-25. (Pubitemid 41427619)
14. Fu Y, Yang S, Jeong SH, Kimura S, Park K. Orally fast disintegrating tablets: Developments, technologies, taste-masking and clinical studies Crit Rev Ther Drug Carrier Syst 2004;21:433-76.
15. Amidon GL, Lennernas H, Shah VP, Crison JR. Theoritical basis for a biopharmaceutics drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995;12:413-20.
16. Lindenberg M, Kopp S, Dressman JR. Classification of orally administered drugs on the world health organization model list of essential medicines according to the biopharmaceutical classification system. Eur J Pharm Biopharm 2004;58:265-278. (Pubitemid 39037234)
17. Sharma S, Gupta GD. Farmulation and charracterization of fast dissolving tablet of promethazine theoclate. Asian J Pharm 2008;2:70-72.
18. Dario L, Maria GB, Maria CL, Claudio JS. Development of prednisone: Polyethylene glycol 6000 fast release tablets from solid dispersion: Solid state characterization, dissolution behaviour, and formulation parameters. AAPS Pharm Sci Tech 2007;8:221-228.
19. Singh J, Philip AK, Pathak K. Optimization studies on design and evaluation of orodispersible pediatric formulation of indomethacin. AAPS Pharm Sci Tech 2008;9:60-6.
20. Marzia C, Francesca M, Giovanna C, Paola M. Fast dissolving tablets of Glyburide based on ternary solid dispersions with PEG 6000 and surfactants. Drug Deliv 2007;14:247-55.
21. Sussanne B, Margareta D, Bo L, Hans L, Anders P, Marie W, et al. In vitro and In vivo evaluation of new sublingual tablet system for rapid oromucosal absorption using fentanyl citrate as the active substance. Eur J Pharm Sci 2003;20:327-34.
22. Iman SA, Mona HA. in vitro and in vivo evaluation of a fast disintegrating lyophilized dry emulsion tablet containing Griseofulvin. Eur J Pharm Sci 2007;32:58-68.
23. Sam C, Jean PR. Formulation and Production of Rapidly Disintegrating tablets By Lyophilization Using Hydrocholorothiazide as a Model Drug. Int J Pharm 1997;152:215-25.
24. Abdelbary G, Prinderre P, Eouani C, Joachim J, Reynier JP, Piccerelle PH. The Preparation of Orally Disintegrating Tablets Using A Hydrophilic Waxy Binder. Int J Pharm 2004;278:423-33. (Pubitemid 38759514)
25. Raguia AS, Iman SA, Rehab NS. In vitro and In vivo evaluation of nimesulide lyophilized orally disintegrating tablets. Eur J Pharm Biopharm 2009;73:162-71.
26. Verley P, Yarwood R. Zydis-a novel fast dissolving dosage form. Manuf Chem 1990;61:36-7.
27. Jinichi F, Etsuo Y, Yasuo Y, Katsuhide T. Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose. Inter J Pharm 2006;310:101-109
28. Segar H. Drug delivery products and the Zydis fast dissolving dosage. J Pharm Pharmacol 1998;50:375-83.
29. Corveleyn S, Remon J. Formulation of a lyophilised dry emulsion tablet for the delivery of poorly soluble drugs. Int J Pharm 1998;166:65-74. (Pubitemid 28239740)
30. Chandrasekhar R, Hassan Z, AlHusban F, Smith A, Mohammed A. The role of formulation excipients in the development of lyophilized fast-disintegrating tablets. Eur J Pharm Biopharm 2009;72:119-29.
31. Carstensen JT. Pharmaceutics of Solids and Solid Dosage Forms, New York: Wiley Interscience; 1977. p.11-5.
32. Van Campen L, Zografi G, Carstensen JT. An approach to the evaluation of hygroscopicity for pharmaceutical solids. Int J Pharm 1980;5:1-18
33. Chang RK, Guo X, Burnside BA, Couch RA. Fast-dissolving tablets. Pharm Technol N Am 2000;24:52-8. (Pubitemid 30450499)
34. Blank RG, Mody DS, Kenny RJ, Aveson MC. Fast dissolving dosage form. US Patent 4,946,684, Aug 7, 1990
35. Green R, Kearney P. Process for preparing fast dispersing solid dosage form. US Patent 5,976,577,Nov 2, 1999.
36. Lawrence J, Posage G. Bicovex rapidly disintegrating dosage form. US Patent 6,224,905, Dec 3, 1998.
37. Simone S, Peter CS. Fast dispersing ibuprofen tablets. Eur J Pharm Sci 2002;15:295-305.
38. Katzner L, Jones B, Khattar J, Kosewick J. Blister package and packaged tablet. US Patent 6,155,423, December 5, 2000.
39. Jaccard TT, Leyder J. A new galenic form: lyoc, Ann Pharm Fr 1985;43:123-31.
40. Lafon L. Galenic form for oral administration and its method of preparation by lyophilization of an oil-in-water emulsion, US Patent 4616047, Oct 7, 1986.
41. Gole D, Savall T, fu GL, Dale W, Paul K, Davies JD. Tastemasked resinate and preparation thereof, US Patent application 20050036977. Feb 17, 2005.
42. Iles MC, Atherton AD, Copping NM. Freeze-dried dosage forms and methods for preparing the same, US Patent 5,188,825. Feb 23, 1993.
43. Ford J. The current status of solid dispersion. Pharm Acta Helv 1986;61:69-88.
44. Dobetti L. Fast melting tablets: Developments and technologies. Pharm Technol Drug Deliv 2001;(Suppl):44-50.
45. Suresh B, Rajendar KM, Ramesh G, Yamsani MR. Orodispersible tablets: An overview. Asian J Pharm 2008;2:2-11.
46. Bi Y, Sunada H, Yorinobu Y, Danjo K, Otsuka A, Iida K. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem Pharm Bull 1996;44:2121-7. (Pubitemid 26396765)
47. Watanabe Y, Koizumi K, Zama Y, Kiriyama M, Matsumoto Y, Matsumoto M. New compressed tablet rapidly disintegrating in saliva in the mouth using crystalline cellulose and a disintegrant. Biol Pharm Bull 1995;18:1308-10.
48. Bi Y, Yorinobu Y, Sunada H. Rapidly disintegrating tablets prepared by wet compression method: Mechanism and optimization. J Pharm Sci 1999;88:1004-10. (Pubitemid 29480591)
49. Sunada H, Bi Y. Preparation, evaluation and optimization of rapidly disintegrating tablets. Powder Technol 2002;122:188-98. (Pubitemid 34041549)
50. Di CM. Flashtab and T-Mask Technologies, Paper presented at: Proceedings of the 7th International Glatt Symposium 1997;1-9.
51. Cousin G, Bruna E, Gendrot E. Rapidly disintegratable multiparticulate tablet, US Patent 5,464, 632., Nov 7, 1995.
52. Khankari R, Hontz J, Chastain S, Katzner L. Rapidly dissolving robust dosage form. US Patent 6,024,981, February 15, 2000.
53. CIMA LABS Inc., "Easy-to-take orally disintegrating tablets", available from: http://www.cimalabs.com/orallydisintegratingtablets. [Last cited on 2011 Jun 30].
54. Chang RK, Xiaodi B, Beth A, Couch RA. Fast-dissolving tablets. Pharm Technol 2000;24:52-8. (Pubitemid 30450499)
55. Yamanouchi Pharma Technologies, Inc. WOWTAB, available from: http://www.imagesrising.com [Last cited on 2011 Jun 30].
56. Pather SI, Khankari R, Siebert J. "Quick-dissolving intraoral tablets" in Drug Delivery to the Oral Cavity: Molecules to Market, In: Ghosh TK, Pfister WR, Editors. New York, NY: CRC Press; 2005. p. 291-310.
57. Bytul MR, Mir Imam IW, Proma K, Maruf A, Robiul I, Ranjan KB, et al. Effect of starch 1500 as a binder and disintegrant in lamivudine tablets prepared by high shear wet granulation. Pak J Pharm Sci 2008;21:455-9.
58. Madhu KV. Coprecipitates and Melts. In: Swarbrick J, Boylen JC, Editors. 'Encyclopedia of Pharmaceutical Technology', Vol. 1, 3rd ed, Pinehurst, North California, USA: Pharmaceutics Inc. 2007.p. 774-81
59. Giunchedi P, Conti B, Genta I, Conte U, Puglisi G. Emulsion spray drying for the preparation of albumin-loaded PLGA microspheres. Drug Dev India Pharm 2001;27:745-50. (Pubitemid 33051612)
60. Alysson LR, Wanderley PO. Spray drying conditions and encapsulating composition effects on formation and properties of sodium diclofenac microparticles. Powder Technol 2007;171:7-14.
61. Donald LW. Handbook of Pharmaceutical Controlled Release Technology, 1st ed, New York: Marcel Dekker Inc.; 2005. p. 112-3.
62. Lieberman HA, Lachman L, Schwartz JB. Pharmaceutical Dosage Forms: Tablets, 2nd ed, Vol. 3, New York: Marcel Dekker Inc; 2005. p. 187.
63. Allen LV, Wang B. Process for making a Particulate Support Matrix for Making a Rapidly Dissolving Dosage Form. US Patent 6,207,199; 2001.
64. Allen LV, Wang B. Process for making a Particulate Support Matrix for Making a Rapidly Dissolving Tablet. US Patent 5,587,180, 1996.
65. Allen LV, Wang B, Davis LD. Rapidly Dissolving Tablet. US Patent 5,807,576; 1998.
66. Jianchen X, Li LB, Kang Z. Taste masking microspheres for orally disintegrating tablets. Int J Pharm 2008;359:63-9.
67. Honey G, Parshuram R, Vikas R, Ashok KT. Orally disintegrating systems: Innovations in formulation and technology. Recent Pat Drug Deliv Formul 2008;2:258-74.
68. Misra TK, Currington JW, Montwill BK, Satish V, Sanghvi PP, Sisak JR, et al. US20006048541 2000.
69. Roser BJ, Blair J. Rapidly soluble oral dosage forms, methods of making same, and composition thereof. US Patent 5,762,961, June 9, 1998.
70. Jinichi F, Etsuo Y, Yasuo Y, Katsuhide T. Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose. Int J Pharm 2006;310:101-9.
71. Johnson JR, Wang LH, Gordon MS, Chowhan ZT. Effect of formulation solubility and hygroscopicity on disintegrating efficiency in tablets prepared by wet granulation. J Pharm Sci 1991;80:469-71.
72. Anand V, Kandarapu R, Garg S. Preparation and evaluation of taste-masked orally disintegrating tablets of prednisolone. Asian J Pharm Sci 2007;2:227-38.
73. Sumitha C, Karuna SN, Divya B, Madhavi K, Vimal KV, Charbe NN. Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid-disintegrating films, Int J Chem Res 2009;1:24-7.
74. Koizumi K, Watanable Y, Morita K, Utoguchi N, Matsumoto M. New Method of preparing high-porosity rapidly saliva soluble compressed tablets using mannitol with camphor: A subliming material. Int J Pharm 1997;152:127-31. (Pubitemid 27254969)
75. Adjei A, Doyle R, Reiland T, Swarbrick J, Boylan JC. Editors. Encyclopedia of Pharmaceutical Technology, Vol. 6, New York: Marcel Dekker; 1992. p. 117.
76. Billany MR, Aulton ME. Ediotrs; Pharmaceutics; The science of Dosage form Design, International Edition, New York: Churchill Livingstone; 1996. p. 263.
77. Catania JS, Johnson AD. U. S. Patent 5633006, 1997.
78. Nelson SL. U.S. Patent 5766622, 1998.
79. Eby III, Georage A. U.S. Patent 5002970, 1991.
80. Pandya HB, Callan TP. U.S. Patent 5.837, 286, 1998.
81. Chang RK, Guo X, Burnside B, Couch R. Fast-dissolving tablets. Pharm Technol 2000;24:52-8. (Pubitemid 30450499)
82. Morella AM, Pitman IH, Heinicke GW. Taste masked liquid suspensions. US Patent 6,197,348. 2001.
83. Tian W, Langride J. Fast dissolving and taste masked oral dosage form comprising sildenafil. Patent WO2004017976. 2004.
84. Corbo M, Desai J, Patell M. U.S. Patent 6.663.893, 2003.
85. Friend DR, Steve N, Sarabia RF, Weber TP, Geoffory J. U.S. Patent, 6, 139.865, 2000.
86. Augello M, Dell SM, Reier GE, Stamato HJ, DiMemmo LM. U.S. Patent, 6099.865, 2000.
87. Kato M. Japan Patent, 8259466, 1996.
88. Maccari M, Calanchi M, Kydonieus AF. Editors; Controlled Release Technologies, Methods, Theory and Applications, 1st edition, Vol. 2, Boca, Raton, Florida: CRS Press, Incl; 1980. p. 113.
89. Narazaki R, Harada T, Takami N, Kato Y, Ohwaki T. A new method for disintegration studies for Rapid Disintegrating Tablet. Chem Pharm Bull 2004;52:704-7. (Pubitemid 41685508)
90. Fu Y, Jeong SH, Park K. Preparation of Fast Dissolving Tablets Based on Mannose. Polym Mater Sci Eng Preprint 2003;89:821-2.
91. Dor PJ, Fix JA. In vitro determination of disintegration time of quick- dissolving tablets using a new method. Pharm Dev Technol 2002;7:361-71.
92. Mortia Y, Tsushima Y, Yasui M, Termoz R, Ajioka J, Takayama K. Evaluation of the disintegration time of rapidly disintegrating tablets via a novel method utilizing a CCD camera. Chem Pharm Bull 2002;50:1181-6. (Pubitemid 41656829)
93. Kancke J. Dissolution testing of orally disintegrating tablets. Disso Tech 2003;10:6-8.
94. Wehling F, Schuehle S, Madamala N. Effervescent dosage form with microparticles. US Patent 5,178,878, January 12, 1993.
95. Yamanouchi Pharmaceutical Co. Press release: Open Yamanouchi Shaklee Pharma Research Center at Stanford Research Park, November 24, 1997.
96. Mizumoto T, Masuda Y, Fukui M. Intrabuccally dissolving compressed molding and production process thereof. U.S. Patent 5,576,014. November 19, 1996.
97. Mizumoto T, Masuda Y, Fukui M. Intrabuccally dissolving compressed moldings and production process thereof. US Patent 5,576,014, November 19, 1996.
98. Pebley WS, Jager NE, Thompson SJ. Rapidly Disintegrating Tablets. US Patent 5,298,261, March 29, 1994.
99. Cremer K. Fast dissolving technologies in detail: Orally disintegrating dosage forms. Pharma Concepts, Humberg, Germany, GmbH and Co. KG; 2001. p. 62-97.
100. Jeong SH, Fu Y, Park K. Frosta: A new technology for making fastmelting tablets. Expert Opin Drug Deliv 2005;2:1107-16. (Pubitemid 41701208)
101. Laboratoire L. Galenic form for oral administration and its method of preparation by lyophilization of an oil-in-water emulsion. Eur Pat 0,159,237,1985.
102. Kovacic M, Milovac J, Cvelbar P, Stalc A, TrostZ, Kopitar Z. Dispersible cimetidine tablets. US Patent 5,069,910; 1991.
103. Fu Y, Yang S, Jeong SH, Kimura S, Park K. Orally fast disintegrating tablets: Developments, technologies, tastemasking and clinical studies. Crit Rev Ther Drug Carrier Sys 2004;21:433-76.
104. Sharma K, Pfister WR, Ghosh TK. "Quick-dispersing oral drug delivery systems" in Drug Delivery to the Oral Cavity: Molecules to Market, In: Ghosh TK, Pfister WR, Editors. New York, NY: CRC Press; 2005. p. 261-90.